naproxen has been researched along with edoxaban in 2 studies
| Studies (naproxen) | Trials (naproxen) | Recent Studies (post-2010) (naproxen) | Studies (edoxaban) | Trials (edoxaban) | Recent Studies (post-2010) (edoxaban) |
|---|---|---|---|---|---|
| 4,551 | 1,057 | 1,429 | 910 | 178 | 873 |
| Protein | Taxonomy | naproxen (IC50) | edoxaban (IC50) |
|---|---|---|---|
| Coagulation factor X | Homo sapiens (human) | 0.0034 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Chen, S; Lee, F; Mendell, J; Samama, MM; Shi, M; Worland, V | 1 |
1 trial(s) available for naproxen and edoxaban
| Article | Year |
|---|---|
The effects of the antiplatelet agents, aspirin and naproxen, on pharmacokinetics and pharmacodynamics of the anticoagulant edoxaban, a direct factor Xa inhibitor.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Blood Physiological Phenomena; Cohort Studies; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Factor Xa Inhibitors; Female; Humans; Male; Middle Aged; Naproxen; Platelet Aggregation Inhibitors; Pyridines; Thiazoles; Young Adult | 2013 |
1 other study(ies) available for naproxen and edoxaban
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |